XOMA Royalty Corporation Common Stock (XOMA) is a publicly traded Healthcare sector company. As of May 21, 2026, XOMA trades at $41.98 with a market cap of $522.21M and a P/E ratio of 25.40. XOMA moved +1.04% today. Year to date, XOMA is +57.70%; over the trailing twelve months it is +57.82%. Its 52-week range spans $18.35 to $42.81. Analyst consensus is neutral with an average price target of $42.67. Rallies surfaces XOMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
XOMA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XOMA recently traded at $41.98. Market cap is $522.21M. P/E ratio is 25.40. Revenue is $48.55M.
| Metric | Value |
|---|---|
| Price | $41.98 |
| Market Cap | $522.21M |
| P/E Ratio | 25.40 |
| EPS | $1.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.81 |
| 52-Week Low | $18.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $48.55M |
| Net Income | $33.81M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $52.15M | $31.71M | $1.53 |
| 2024 | $28.49M | $-13.82M | $-1.65 |
| 2023 | $4.76M | $-40.83M | $-4.04 |
| 2022 | $6.03M | $-17.10M | $-1.98 |
4 analysts cover XOMA: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $42.67.